Purchases and Sales Made in Q1 2025 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q1 2025. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2025
Q1 2025
|
American Century Companies Inc
Kansas City, MO |
SELL
|
- |
-176K- 26.27% |
$10.8M - $12.8M
|
495K
$29.5M
|
|
|
May 14, 2025
Q1 2025
|
Ray Dalio
Bridgewater Associates, LP | Westport, Ct
|
SELL
|
- |
-179K- 59.12% |
$11M - $13M
|
124K
$7.38M
|
|
|
May 02, 2025
Q1 2025
|
Victory Capital Management Inc
|
SELL
|
- |
-208K- 74.71% |
$12.7M - $15.1M
|
70.2K
$4.19M
|
|
|
Apr 14, 2025
Q1 2025
|
Gamma Investing LLC
Foster City, CA |
SELL
|
- |
-218K- 98.59% |
$13.4M - $15.9M
|
3.13K
$187K
|
|
|
May 14, 2025
Q1 2025
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-293K- 6.5% |
$17.9M - $21.3M
|
4.21M
$251M
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-298K- 22.2% |
$18.2M - $21.7M
|
1.04M
$62.2M
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-329K- 21.25% |
$20.1M - $23.9M
|
1.22M
$72.6M
|
|
|
May 15, 2025
Q1 2025
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-329K- 97.7% |
$20.2M - $24M
|
7.75K
$462K
|
|
|
May 09, 2025
Q1 2025
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-369K- 1.9% |
$22.6M - $26.9M
|
19M
$1.13B
|
|
|
May 09, 2025
Q1 2025
|
Primecap Management CO
Pasadena, CA |
SELL
|
- |
-416K- 2.29% |
$25.5M - $30.3M
|
17.8M
$1.06B
|
|
|
May 14, 2025
Q1 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-460K- 77.66% |
$28.2M - $33.5M
|
132K
$7.9M
|
|
|
May 15, 2025
Q1 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-649K- 7.12% |
$39.8M - $47.3M
|
8.46M
$505M
|
|
|
May 15, 2025
Q1 2025
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-666K- 97.89% |
$40.8M - $48.5M
|
14.3K
$855K
|
|
|
May 12, 2025
Q1 2025
|
Capital Research Global Investors
Los Angeles, CA |
SELL
|
- |
-3.84M- 29.57% |
$235M - $280M
|
9.15M
$546M
|